Too often in clinical research, pharma companies “helicopter in” to a community when enrollment targets loom, only to disappear once the trial ends. Communities notice. And that approach leaves people feeling used, not valued, making future engagemen...
Director of Pharmaceutical Sales, Acclinate 
